Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...

Q2 2025 Management View CEO Kim Kelderman highlighted 9% organic revenue growth for the quarter, driven by strong performance in biopharma end markets, particularly large pharma, which benefited GMP ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

Nepal Ausadhi Limited has been awarded with the Good Manufacturing Practice (GMP) certificate, meeting the World Health ...

Kolkata: The West Bengal health dept asked a saline manufacturing unit, which is a major supplier to govt hospitals, to stop manufacturing the product.

Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.

AmplifyBio, a leading preclinical CRO and CDMO played a pivotal role in shaping discussions at Phacilitate’s Advanced Therapy ...

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

HYTN will endeavour to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.